학술논문
Interim data of effectiveness and safety of nivolumab plus ipilimumab combination therapy (NIVO plus IPI) in first line (1L) advanced/metastatic renal cell carcinoma (aRCC) from the German non-interventional study (NIS) NORA
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
22965262